Telix Pharmaceuticals Files 6-K Report
Ticker: TLX · Form: 6-K · Filed: Apr 10, 2026 · CIK: 0002007191
| Field | Detail |
|---|---|
| Company | Telix Pharmaceuticals Ltd (TLX) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-update
TL;DR
Telix Pharma dropped a 6-K filing on 4/10/26 - check it for Pixclara updates and financials.
AI Summary
On April 10, 2026, Telix Pharmaceuticals Ltd. filed a 6-K report with the SEC. The filing includes financial information and exhibits, such as a press release regarding Pixclara, a new imaging agent. The company's mailing and business address is 55 Flemington Road, North Melbourne, C3 3051.
Why It Matters
This filing provides an update on Telix Pharmaceuticals' corporate activities and financial reporting, which is important for investors tracking the company's progress and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine 6-K filing providing corporate information and is not indicative of immediate material changes.
Key Players & Entities
- Telix Pharmaceuticals Ltd (company) — Filer of the 6-K report
- Pixclara (product) — Mentioned in an exhibit to the 6-K
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the issuer makes or is required to make public pursuant to the laws of its home country or its home country's stock exchange, or that it otherwise makes or is required to make public.
When was this 6-K filing accepted by the SEC?
This 6-K filing was accepted by the SEC on April 9, 2026.
What is the CIK number for Telix Pharmaceuticals Ltd?
The CIK number for Telix Pharmaceuticals Ltd is 0002007191.
What is the SIC code listed for Telix Pharmaceuticals Ltd?
The SIC code listed for Telix Pharmaceuticals Ltd is 2834, which corresponds to Pharmaceutical Preparations.
What documents are included in this 6-K submission?
This 6-K submission includes the main 6-K document, an exhibit (EX-99.1), and several graphic files, along with a complete submission text file.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2026 regarding Telix Pharmaceuticals Ltd (TLX).